Patent ID: 7084117

Claim:
A method of treating vascular proliferation in a patient, said method comprising administering a therapeutically effective amount of a somatostatin type-1 receptor agonist to said patient wherein said somatostatin type-1 receptor agonist is a somatostatin type-1 receptor selective agonist having a Ki for the somatostatin type-1 receptor which is less than 5 nM and at least 10 times less than the Ki for said somatostatin type-1 receptor agonist for each of the somatostatin type-2, type-3, type-4, and type-5 receptors provided that said somatostatin type-1 receptor agonist is not H-D-Phe-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-NH 2 or 3-((2,4-dimethylpyrrol-5-yl) methylidenyl)-2-indolinone.